Black Diamond Therapeutics (BDTX) Shares Outstanding (Diluted Average) (2020 - 2021)
Historic Shares Outstanding (Diluted Average) for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q3 2021 value amounting to $36.2 million.
- Black Diamond Therapeutics' Shares Outstanding (Diluted Average) rose 81.18% to $36.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $36.2 million, marking a year-over-year increase of 81.18%. This contributed to the annual value of $32.9 million for FY2020, which is N/A changed from last year.
- Black Diamond Therapeutics' Shares Outstanding (Diluted Average) amounted to $36.2 million in Q3 2021, which was up 81.18% from $36.2 million recorded in Q2 2021.
- Black Diamond Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $36.2 million for Q3 2021, and its period low was $23.7 million during Q1 2020.